Sally Stabler
Concepts (824)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin B 12 Deficiency | 63 | 2026 | 81 | 6.850 |
Why?
| | Vitamin B 12 | 61 | 2026 | 139 | 5.670 |
Why?
| | Homocysteine | 79 | 2024 | 152 | 5.080 |
Why?
| | Homocystinuria | 18 | 2024 | 62 | 3.610 |
Why?
| | Folic Acid | 53 | 2026 | 198 | 3.230 |
Why?
| | Methionine | 40 | 2021 | 161 | 2.920 |
Why?
| | Methylmalonic Acid | 54 | 2017 | 66 | 2.830 |
Why?
| | Folic Acid Deficiency | 27 | 2021 | 49 | 2.620 |
Why?
| | Cystathionine beta-Synthase | 17 | 2024 | 65 | 2.090 |
Why?
| | Liver | 29 | 2024 | 1916 | 1.970 |
Why?
| | Betaine | 19 | 2024 | 67 | 1.870 |
Why?
| | S-Adenosylmethionine | 22 | 2020 | 59 | 1.700 |
Why?
| | S-Adenosylhomocysteine | 17 | 2020 | 24 | 1.680 |
Why?
| | Hyperhomocysteinemia | 14 | 2020 | 26 | 1.550 |
Why?
| | Vitamin B Complex | 10 | 2020 | 39 | 1.490 |
Why?
| | Amino Acids, Sulfur | 4 | 2020 | 8 | 1.340 |
Why?
| | Nutritional Status | 8 | 2020 | 353 | 1.010 |
Why?
| | Cysteine | 12 | 2020 | 211 | 1.000 |
Why?
| | Betaine-Homocysteine S-Methyltransferase | 3 | 2019 | 9 | 0.940 |
Why?
| | Taurine | 4 | 2019 | 41 | 0.930 |
Why?
| | Tetrahydrofolates | 2 | 2024 | 16 | 0.900 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2024 | 22 | 0.840 |
Why?
| | Sulfur | 3 | 2020 | 60 | 0.740 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 9 | 2021 | 36 | 0.710 |
Why?
| | Oxidation-Reduction | 5 | 2024 | 1077 | 0.700 |
Why?
| | Choline | 11 | 2017 | 138 | 0.690 |
Why?
| | Dietary Supplements | 15 | 2020 | 586 | 0.670 |
Why?
| | Sulfur Compounds | 1 | 2020 | 7 | 0.650 |
Why?
| | Methionine Adenosyltransferase | 6 | 2020 | 10 | 0.650 |
Why?
| | Metabolic Diseases | 1 | 2020 | 114 | 0.580 |
Why?
| | Anemia | 6 | 2014 | 192 | 0.580 |
Why?
| | Glycine Hydroxymethyltransferase | 7 | 2026 | 16 | 0.580 |
Why?
| | Neural Tube Defects | 5 | 2026 | 67 | 0.570 |
Why?
| | Anemia, Megaloblastic | 6 | 2020 | 9 | 0.490 |
Why?
| | Methylation | 12 | 2020 | 242 | 0.490 |
Why?
| | Cystathionine | 14 | 2012 | 22 | 0.470 |
Why?
| | Diet | 12 | 2013 | 1284 | 0.460 |
Why?
| | Animals | 67 | 2026 | 38410 | 0.450 |
Why?
| | Humans | 164 | 2026 | 147293 | 0.440 |
Why?
| | Iron, Dietary | 1 | 2014 | 23 | 0.430 |
Why?
| | Female | 120 | 2026 | 80076 | 0.420 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2014 | 62 | 0.420 |
Why?
| | Adenosylhomocysteinase | 5 | 2021 | 9 | 0.410 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 4 | 2017 | 18 | 0.410 |
Why?
| | Mice | 35 | 2026 | 18491 | 0.400 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 4 | 2015 | 25 | 0.400 |
Why?
| | Aged, 80 and over | 34 | 2017 | 8430 | 0.400 |
Why?
| | Gas Chromatography-Mass Spectrometry | 16 | 2020 | 125 | 0.400 |
Why?
| | Glutathione | 8 | 2020 | 370 | 0.390 |
Why?
| | Disease Models, Animal | 16 | 2026 | 4604 | 0.370 |
Why?
| | Male | 104 | 2026 | 73950 | 0.370 |
Why?
| | Cognition Disorders | 5 | 2011 | 551 | 0.350 |
Why?
| | Dose-Response Relationship, Drug | 11 | 2020 | 2030 | 0.330 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 4 | 2017 | 8 | 0.330 |
Why?
| | Isoenzymes | 5 | 2012 | 296 | 0.330 |
Why?
| | Frail Elderly | 2 | 2010 | 136 | 0.320 |
Why?
| | Biomarkers | 19 | 2020 | 4351 | 0.320 |
Why?
| | Aged | 59 | 2017 | 26514 | 0.320 |
Why?
| | Metabolism, Inborn Errors | 5 | 2020 | 42 | 0.310 |
Why?
| | Hydrogen Sulfide | 2 | 2020 | 47 | 0.310 |
Why?
| | Carbon | 3 | 2024 | 176 | 0.310 |
Why?
| | Receptors, Cell Surface | 3 | 2015 | 373 | 0.310 |
Why?
| | Methylmalonyl-CoA Mutase | 9 | 2017 | 11 | 0.310 |
Why?
| | Uracil | 4 | 2021 | 37 | 0.310 |
Why?
| | Cystathionine gamma-Lyase | 4 | 2020 | 13 | 0.300 |
Why?
| | Thioctic Acid | 1 | 2009 | 12 | 0.300 |
Why?
| | Thrombosis | 2 | 2011 | 401 | 0.290 |
Why?
| | Abortion, Spontaneous | 1 | 2009 | 119 | 0.280 |
Why?
| | Adult | 70 | 2026 | 41405 | 0.280 |
Why?
| | Vitamin B Deficiency | 1 | 2008 | 1 | 0.280 |
Why?
| | Eubacterium | 1 | 2008 | 3 | 0.280 |
Why?
| | DNA | 8 | 2020 | 1444 | 0.280 |
Why?
| | Propionibacterium | 1 | 2008 | 3 | 0.280 |
Why?
| | Middle Aged | 57 | 2020 | 36821 | 0.270 |
Why?
| | Intestinal Absorption | 3 | 2013 | 103 | 0.270 |
Why?
| | Up-Regulation | 3 | 2017 | 848 | 0.270 |
Why?
| | Feces | 3 | 2019 | 500 | 0.260 |
Why?
| | Acyl Coenzyme A | 5 | 2006 | 32 | 0.260 |
Why?
| | Pregnancy | 17 | 2020 | 7274 | 0.250 |
Why?
| | Diabetic Neuropathies | 2 | 2026 | 100 | 0.250 |
Why?
| | Malnutrition | 1 | 2008 | 87 | 0.250 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2026 | 134 | 0.250 |
Why?
| | Mice, Knockout | 11 | 2026 | 3153 | 0.250 |
Why?
| | Mice, Inbred C57BL | 12 | 2024 | 6041 | 0.250 |
Why?
| | Dietary Services | 2 | 2005 | 2 | 0.250 |
Why?
| | Prevalence | 13 | 2017 | 2889 | 0.240 |
Why?
| | Corrinoids | 2 | 2019 | 7 | 0.240 |
Why?
| | Nutrition Assessment | 1 | 2006 | 91 | 0.240 |
Why?
| | Sulfhydryl Compounds | 4 | 2018 | 189 | 0.240 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2021 | 269 | 0.230 |
Why?
| | Amino Acids | 6 | 2020 | 519 | 0.230 |
Why?
| | Antioxidants | 1 | 2009 | 550 | 0.230 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 7 | 2017 | 18 | 0.220 |
Why?
| | Human papillomavirus 16 | 2 | 2018 | 27 | 0.220 |
Why?
| | Transcobalamins | 3 | 2017 | 3 | 0.220 |
Why?
| | Disease Progression | 3 | 2011 | 2890 | 0.210 |
Why?
| | Vitamin B 6 | 2 | 2003 | 11 | 0.210 |
Why?
| | Geriatrics | 2 | 2003 | 96 | 0.200 |
Why?
| | Administration, Oral | 8 | 2019 | 874 | 0.200 |
Why?
| | Prostatic Neoplasms | 1 | 2011 | 986 | 0.200 |
Why?
| | Maternal Nutritional Physiological Phenomena | 3 | 2015 | 178 | 0.200 |
Why?
| | Mutation | 11 | 2017 | 4130 | 0.200 |
Why?
| | Brain Diseases | 2 | 2020 | 158 | 0.200 |
Why?
| | Food, Fortified | 4 | 2010 | 44 | 0.200 |
Why?
| | Rumen | 3 | 2014 | 9 | 0.200 |
Why?
| | Gestational Age | 3 | 2020 | 997 | 0.200 |
Why?
| | Rats | 18 | 2016 | 5613 | 0.190 |
Why?
| | Methylenetetrahydrofolate Dehydrogenase (NADP) | 2 | 2012 | 2 | 0.190 |
Why?
| | Uterine Artery | 2 | 2020 | 74 | 0.180 |
Why?
| | Apolipoproteins E | 5 | 2013 | 96 | 0.180 |
Why?
| | Fetal Blood | 5 | 2013 | 327 | 0.180 |
Why?
| | Neonatal Screening | 2 | 2007 | 185 | 0.180 |
Why?
| | Ferredoxin-NADP Reductase | 3 | 2012 | 3 | 0.180 |
Why?
| | Hearing Loss | 1 | 2006 | 252 | 0.180 |
Why?
| | Heterozygote | 4 | 2015 | 317 | 0.170 |
Why?
| | Cohort Studies | 11 | 2020 | 6099 | 0.170 |
Why?
| | Metabolic Networks and Pathways | 2 | 2015 | 175 | 0.170 |
Why?
| | Nutrition Surveys | 3 | 2011 | 279 | 0.170 |
Why?
| | Mice, Transgenic | 8 | 2014 | 2197 | 0.170 |
Why?
| | Cattle | 3 | 2014 | 948 | 0.160 |
Why?
| | Lactation | 4 | 2015 | 195 | 0.160 |
Why?
| | Body Mass Index | 1 | 2009 | 2470 | 0.160 |
Why?
| | Sulfites | 1 | 2020 | 8 | 0.160 |
Why?
| | Polyamines | 1 | 2021 | 42 | 0.160 |
Why?
| | Protein Biosynthesis | 1 | 2004 | 452 | 0.160 |
Why?
| | Formate-Tetrahydrofolate Ligase | 2 | 2012 | 2 | 0.160 |
Why?
| | Anemia, Pernicious | 3 | 2013 | 6 | 0.160 |
Why?
| | Liver Diseases, Alcoholic | 3 | 2011 | 98 | 0.160 |
Why?
| | Fetal Growth Retardation | 2 | 2020 | 594 | 0.160 |
Why?
| | Brazil | 4 | 2009 | 179 | 0.160 |
Why?
| | Global Health | 1 | 2004 | 406 | 0.160 |
Why?
| | Aging | 7 | 2010 | 1992 | 0.160 |
Why?
| | Carrier Proteins | 3 | 2014 | 731 | 0.160 |
Why?
| | Polymorphism, Genetic | 4 | 2015 | 615 | 0.150 |
Why?
| | Animals, Newborn | 3 | 2007 | 914 | 0.150 |
Why?
| | Virus Integration | 2 | 2018 | 69 | 0.150 |
Why?
| | Reference Values | 12 | 2010 | 800 | 0.150 |
Why?
| | Erythrocytes | 8 | 2011 | 749 | 0.150 |
Why?
| | Aminobutyrates | 2 | 2018 | 31 | 0.150 |
Why?
| | Genetic Diseases, Inborn | 2 | 2004 | 45 | 0.150 |
Why?
| | Umbilical Arteries | 1 | 2020 | 52 | 0.150 |
Why?
| | Depressive Disorder | 2 | 2000 | 379 | 0.150 |
Why?
| | Caenorhabditis elegans | 2 | 2017 | 330 | 0.150 |
Why?
| | Gene Rearrangement | 1 | 2020 | 156 | 0.150 |
Why?
| | Bacteroides | 1 | 2019 | 20 | 0.150 |
Why?
| | Isomerases | 3 | 1988 | 7 | 0.140 |
Why?
| | Carnitine | 2 | 1990 | 91 | 0.140 |
Why?
| | Vitamin B 6 Deficiency | 3 | 2011 | 6 | 0.140 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2026 | 2627 | 0.140 |
Why?
| | Sarcosine | 6 | 2012 | 10 | 0.140 |
Why?
| | Infant, Newborn | 14 | 2020 | 6543 | 0.140 |
Why?
| | Homozygote | 2 | 2015 | 199 | 0.140 |
Why?
| | Genotype | 8 | 2015 | 1875 | 0.140 |
Why?
| | Hemophilia B | 2 | 2003 | 65 | 0.140 |
Why?
| | Chromatography, Liquid | 4 | 2011 | 453 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2011 | 1224 | 0.140 |
Why?
| | Liver Diseases | 2 | 2020 | 307 | 0.130 |
Why?
| | Risk Factors | 15 | 2017 | 11017 | 0.130 |
Why?
| | Sulfinic Acids | 1 | 2018 | 6 | 0.130 |
Why?
| | Mass Spectrometry | 4 | 2017 | 728 | 0.130 |
Why?
| | Adolescent | 28 | 2020 | 22825 | 0.130 |
Why?
| | Georgia | 5 | 2013 | 80 | 0.130 |
Why?
| | Respiratory Hypersensitivity | 1 | 2018 | 65 | 0.130 |
Why?
| | Pyruvaldehyde | 1 | 2018 | 46 | 0.130 |
Why?
| | Infant | 14 | 2015 | 10194 | 0.130 |
Why?
| | Racemases and Epimerases | 2 | 2006 | 11 | 0.130 |
Why?
| | Geriatric Assessment | 4 | 2013 | 240 | 0.130 |
Why?
| | Young Adult | 17 | 2020 | 14437 | 0.130 |
Why?
| | Genetic Variation | 2 | 2015 | 995 | 0.130 |
Why?
| | Phosphatidylcholines | 5 | 2013 | 131 | 0.130 |
Why?
| | Lymphoma, AIDS-Related | 2 | 1996 | 14 | 0.130 |
Why?
| | Thymidine Monophosphate | 3 | 2013 | 4 | 0.130 |
Why?
| | Folate Receptor 2 | 1 | 2017 | 8 | 0.130 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2017 | 117 | 0.120 |
Why?
| | Methyltransferases | 5 | 2008 | 75 | 0.120 |
Why?
| | DNA, Mitochondrial | 3 | 2021 | 212 | 0.120 |
Why?
| | ROC Curve | 2 | 2011 | 626 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 536 | 0.120 |
Why?
| | Hematinics | 2 | 2006 | 22 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2015 | 2223 | 0.120 |
Why?
| | Child, Preschool | 17 | 2020 | 12016 | 0.120 |
Why?
| | Carcinogenesis | 1 | 2018 | 230 | 0.120 |
Why?
| | Crosses, Genetic | 2 | 2013 | 123 | 0.120 |
Why?
| | Thromboembolism | 2 | 2015 | 129 | 0.120 |
Why?
| | Propionates | 3 | 2017 | 39 | 0.120 |
Why?
| | Lung | 5 | 2012 | 4141 | 0.120 |
Why?
| | Diabetic Nephropathies | 1 | 1999 | 322 | 0.110 |
Why?
| | Stomach | 1 | 1996 | 111 | 0.110 |
Why?
| | Hydroxocobalamin | 3 | 1990 | 33 | 0.110 |
Why?
| | Alleles | 5 | 2009 | 909 | 0.110 |
Why?
| | Genome | 1 | 2018 | 306 | 0.110 |
Why?
| | Linear Models | 5 | 2010 | 852 | 0.110 |
Why?
| | Neoplasms, Experimental | 2 | 2017 | 167 | 0.110 |
Why?
| | Phospholipids | 1 | 2017 | 214 | 0.110 |
Why?
| | Glycine N-Methyltransferase | 3 | 2011 | 4 | 0.110 |
Why?
| | Keratinocytes | 2 | 2018 | 249 | 0.110 |
Why?
| | Weight Gain | 2 | 2016 | 566 | 0.110 |
Why?
| | Alcoholism | 2 | 2020 | 838 | 0.110 |
Why?
| | Age Factors | 6 | 2010 | 3372 | 0.110 |
Why?
| | Kidney Failure, Chronic | 2 | 2020 | 600 | 0.110 |
Why?
| | Thymidylate Synthase | 2 | 2011 | 13 | 0.110 |
Why?
| | Choline Deficiency | 3 | 2012 | 10 | 0.110 |
Why?
| | Double-Blind Method | 7 | 2015 | 2080 | 0.110 |
Why?
| | Biochemistry | 1 | 2015 | 36 | 0.110 |
Why?
| | Hemophilia A | 2 | 1996 | 149 | 0.110 |
Why?
| | Host Cell Factor C1 | 1 | 2014 | 15 | 0.110 |
Why?
| | Pilot Projects | 3 | 2020 | 1912 | 0.110 |
Why?
| | RNA, Messenger | 6 | 2017 | 2812 | 0.110 |
Why?
| | Micronutrients | 1 | 2015 | 102 | 0.100 |
Why?
| | Dietary Fats | 1 | 2016 | 309 | 0.100 |
Why?
| | Milk, Human | 2 | 2015 | 176 | 0.100 |
Why?
| | DNA Methylation | 4 | 2018 | 722 | 0.100 |
Why?
| | Diagnosis, Differential | 5 | 2026 | 1518 | 0.100 |
Why?
| | Hemoglobins, Abnormal | 1 | 1994 | 8 | 0.100 |
Why?
| | Placenta | 3 | 2017 | 793 | 0.100 |
Why?
| | Energy Intake | 2 | 2015 | 514 | 0.100 |
Why?
| | Cyanosis | 1 | 1994 | 18 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2020 | 915 | 0.100 |
Why?
| | Child | 16 | 2020 | 22979 | 0.100 |
Why?
| | Blotting, Western | 5 | 2014 | 1186 | 0.100 |
Why?
| | Milk | 1 | 2014 | 119 | 0.100 |
Why?
| | Paresthesia | 2 | 2013 | 14 | 0.100 |
Why?
| | Cross-Sectional Studies | 7 | 2010 | 6011 | 0.100 |
Why?
| | Colitis | 2 | 2019 | 282 | 0.100 |
Why?
| | Drosophila melanogaster | 1 | 2015 | 241 | 0.100 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2020 | 700 | 0.100 |
Why?
| | Women's Health | 3 | 2015 | 317 | 0.100 |
Why?
| | Benzimidazoles | 1 | 2014 | 190 | 0.100 |
Why?
| | Infant Nutrition Disorders | 1 | 2013 | 10 | 0.100 |
Why?
| | Child Nutrition Disorders | 1 | 2013 | 20 | 0.090 |
Why?
| | Analysis of Variance | 5 | 2011 | 1302 | 0.090 |
Why?
| | Time Factors | 7 | 2006 | 7173 | 0.090 |
Why?
| | Malonates | 3 | 1990 | 8 | 0.090 |
Why?
| | Interleukin-1beta | 2 | 2011 | 394 | 0.090 |
Why?
| | Lipid Metabolism | 1 | 2016 | 538 | 0.090 |
Why?
| | Chloroflexi | 1 | 2012 | 12 | 0.090 |
Why?
| | Maternal-Fetal Exchange | 1 | 2013 | 171 | 0.090 |
Why?
| | Apolipoproteins A | 1 | 2012 | 19 | 0.090 |
Why?
| | Aminohydrolases | 1 | 2012 | 3 | 0.090 |
Why?
| | DNA Mutational Analysis | 3 | 2009 | 414 | 0.090 |
Why?
| | Aryldialkylphosphatase | 1 | 2012 | 17 | 0.090 |
Why?
| | Gene Expression Regulation | 3 | 2017 | 2625 | 0.090 |
Why?
| | Cell Transformation, Viral | 1 | 2012 | 23 | 0.090 |
Why?
| | Papillomavirus Infections | 2 | 2018 | 345 | 0.090 |
Why?
| | Apolipoprotein A-I | 1 | 2012 | 39 | 0.090 |
Why?
| | Injections | 1 | 2013 | 200 | 0.090 |
Why?
| | Hemoglobins | 3 | 2011 | 386 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 2 | 2011 | 975 | 0.090 |
Why?
| | Multienzyme Complexes | 1 | 2012 | 65 | 0.090 |
Why?
| | Practice Guidelines as Topic | 2 | 2026 | 1598 | 0.090 |
Why?
| | Bone Density | 1 | 2015 | 493 | 0.090 |
Why?
| | Pyridoxine | 3 | 1996 | 37 | 0.090 |
Why?
| | Logistic Models | 4 | 2013 | 2142 | 0.090 |
Why?
| | Fibroblasts | 6 | 2021 | 1039 | 0.080 |
Why?
| | Neurogenesis | 1 | 2013 | 158 | 0.080 |
Why?
| | Prospective Studies | 12 | 2013 | 8164 | 0.080 |
Why?
| | Diagnostic Errors | 1 | 2013 | 182 | 0.080 |
Why?
| | Zebrafish Proteins | 1 | 2014 | 316 | 0.080 |
Why?
| | Oxidative Stress | 4 | 2019 | 1368 | 0.080 |
Why?
| | Cell Nucleus | 2 | 2011 | 589 | 0.080 |
Why?
| | Superoxide Dismutase | 1 | 1993 | 308 | 0.080 |
Why?
| | Polymorphism, Restriction Fragment Length | 2 | 2008 | 60 | 0.080 |
Why?
| | Mutation, Missense | 4 | 2009 | 337 | 0.080 |
Why?
| | Vitamins | 3 | 2007 | 184 | 0.080 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2011 | 162 | 0.080 |
Why?
| | Hydrops Fetalis | 1 | 2010 | 13 | 0.080 |
Why?
| | Nutritional Requirements | 2 | 2010 | 78 | 0.080 |
Why?
| | Memory | 1 | 2013 | 300 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 980 | 0.080 |
Why?
| | Cell Line | 4 | 2017 | 2832 | 0.080 |
Why?
| | Cognition | 2 | 2013 | 1286 | 0.080 |
Why?
| | Polymerase Chain Reaction | 3 | 2009 | 1046 | 0.080 |
Why?
| | Pregnancy Complications | 2 | 2009 | 606 | 0.080 |
Why?
| | Inflammation | 3 | 2019 | 2920 | 0.080 |
Why?
| | Coenzyme A | 1 | 1990 | 8 | 0.080 |
Why?
| | Sensitivity and Specificity | 5 | 2009 | 2017 | 0.080 |
Why?
| | RNA-Binding Proteins | 3 | 2017 | 451 | 0.080 |
Why?
| | Chemokines | 1 | 2011 | 217 | 0.080 |
Why?
| | Lactams | 1 | 1990 | 28 | 0.080 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 269 | 0.080 |
Why?
| | Creatinine | 4 | 2011 | 516 | 0.080 |
Why?
| | Mice, Nude | 3 | 2018 | 680 | 0.080 |
Why?
| | Hematocrit | 4 | 2002 | 109 | 0.080 |
Why?
| | Proportional Hazards Models | 2 | 2011 | 1344 | 0.080 |
Why?
| | Blood Coagulation | 1 | 2011 | 274 | 0.080 |
Why?
| | Siblings | 1 | 2010 | 197 | 0.070 |
Why?
| | Mitochondrial Proteins | 1 | 2011 | 264 | 0.070 |
Why?
| | Leukocytes | 2 | 2015 | 301 | 0.070 |
Why?
| | Educational Status | 2 | 2003 | 475 | 0.070 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1488 | 0.070 |
Why?
| | Gastrointestinal Contents | 1 | 2009 | 8 | 0.070 |
Why?
| | Endothelium, Vascular | 2 | 2006 | 959 | 0.070 |
Why?
| | Antibodies, Bacterial | 1 | 2010 | 148 | 0.070 |
Why?
| | Treatment Outcome | 8 | 2013 | 11947 | 0.070 |
Why?
| | Kidney | 2 | 2007 | 1511 | 0.070 |
Why?
| | Atherosclerosis | 1 | 2013 | 411 | 0.070 |
Why?
| | Formates | 1 | 2008 | 15 | 0.070 |
Why?
| | Neuropsychological Tests | 3 | 2013 | 1145 | 0.070 |
Why?
| | Glutamate Carboxypeptidase II | 1 | 2008 | 8 | 0.070 |
Why?
| | Reduced Folate Carrier Protein | 1 | 2008 | 9 | 0.070 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 695 | 0.070 |
Why?
| | Amino Acid Isomerases | 1 | 1988 | 1 | 0.070 |
Why?
| | Intramolecular Transferases | 1 | 1988 | 3 | 0.070 |
Why?
| | Deuterium | 3 | 2015 | 102 | 0.070 |
Why?
| | Homeostasis | 2 | 2020 | 651 | 0.070 |
Why?
| | Fatty Liver | 2 | 2010 | 257 | 0.070 |
Why?
| | Biological Availability | 2 | 2010 | 146 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2218 | 0.070 |
Why?
| | Recurrence | 1 | 2011 | 1151 | 0.070 |
Why?
| | Parity | 1 | 2008 | 112 | 0.070 |
Why?
| | Cytoplasm | 1 | 2008 | 255 | 0.070 |
Why?
| | Leucine | 1 | 1988 | 116 | 0.070 |
Why?
| | Folate Receptors, GPI-Anchored | 2 | 2005 | 5 | 0.060 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2007 | 57 | 0.060 |
Why?
| | Oxygen | 1 | 1993 | 998 | 0.060 |
Why?
| | Promoter Regions, Genetic | 1 | 2012 | 1253 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 3 | 2009 | 2542 | 0.060 |
Why?
| | Regression Analysis | 2 | 2000 | 1003 | 0.060 |
Why?
| | Hippocampus | 1 | 2013 | 989 | 0.060 |
Why?
| | Socioeconomic Factors | 3 | 2008 | 1342 | 0.060 |
Why?
| | Molecular Sequence Data | 5 | 2012 | 2886 | 0.060 |
Why?
| | Cobalt | 3 | 2014 | 50 | 0.060 |
Why?
| | Lipids | 1 | 2012 | 723 | 0.060 |
Why?
| | Muscle, Skeletal | 2 | 2007 | 1798 | 0.060 |
Why?
| | Obesity | 1 | 2020 | 3149 | 0.060 |
Why?
| | Base Sequence | 4 | 2015 | 2175 | 0.060 |
Why?
| | Pregnancy Trimester, Third | 2 | 2020 | 119 | 0.060 |
Why?
| | Succinates | 4 | 1991 | 25 | 0.060 |
Why?
| | Fibrinogens, Abnormal | 1 | 2006 | 2 | 0.060 |
Why?
| | Thrombin Time | 1 | 2006 | 13 | 0.060 |
Why?
| | Smoking | 2 | 2012 | 1483 | 0.060 |
Why?
| | Afibrinogenemia | 1 | 2006 | 8 | 0.060 |
Why?
| | Succinic Acid | 4 | 1991 | 46 | 0.060 |
Why?
| | Cardiotonic Agents | 1 | 2006 | 94 | 0.060 |
Why?
| | Cobamides | 1 | 2006 | 25 | 0.060 |
Why?
| | Iron | 2 | 2008 | 361 | 0.060 |
Why?
| | Reproduction | 1 | 2007 | 212 | 0.060 |
Why?
| | Social Class | 2 | 2005 | 266 | 0.060 |
Why?
| | Mitochondria | 3 | 2021 | 1000 | 0.060 |
Why?
| | Dextran Sulfate | 2 | 2019 | 93 | 0.060 |
Why?
| | Homocystine | 1 | 2005 | 1 | 0.060 |
Why?
| | Acquired Immunodeficiency Syndrome | 3 | 1999 | 237 | 0.060 |
Why?
| | Oncogene Proteins, Viral | 2 | 2018 | 20 | 0.060 |
Why?
| | von Willebrand Factor | 2 | 2006 | 85 | 0.060 |
Why?
| | Ganglia, Spinal | 1 | 2026 | 88 | 0.060 |
Why?
| | Severity of Illness Index | 5 | 2011 | 2973 | 0.060 |
Why?
| | Disulfides | 2 | 2008 | 94 | 0.060 |
Why?
| | Recommended Dietary Allowances | 2 | 2015 | 16 | 0.060 |
Why?
| | Acidosis | 1 | 2006 | 107 | 0.060 |
Why?
| | Transfection | 2 | 2006 | 930 | 0.060 |
Why?
| | Brain Edema | 2 | 2003 | 63 | 0.050 |
Why?
| | Fetus | 2 | 2012 | 805 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2011 | 1171 | 0.050 |
Why?
| | Food Services | 1 | 2005 | 21 | 0.050 |
Why?
| | Apoptosis | 2 | 2012 | 2454 | 0.050 |
Why?
| | Zinc | 1 | 2008 | 309 | 0.050 |
Why?
| | Epidemiologic Methods | 1 | 2005 | 91 | 0.050 |
Why?
| | Kidney Diseases | 2 | 2007 | 428 | 0.050 |
Why?
| | Gene Expression | 3 | 2018 | 1481 | 0.050 |
Why?
| | Mass Screening | 3 | 2002 | 1375 | 0.050 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2018 | 268 | 0.050 |
Why?
| | Biomarkers, Tumor | 1 | 2011 | 1339 | 0.050 |
Why?
| | Indicator Dilution Techniques | 1 | 2003 | 12 | 0.050 |
Why?
| | Diet, Vegetarian | 1 | 2004 | 11 | 0.050 |
Why?
| | Liver Cirrhosis | 2 | 2010 | 289 | 0.050 |
Why?
| | Carotid Stenosis | 1 | 2005 | 107 | 0.050 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2006 | 209 | 0.050 |
Why?
| | Hyperoxia | 1 | 2005 | 127 | 0.050 |
Why?
| | Menopause | 1 | 2007 | 328 | 0.050 |
Why?
| | 5' Untranslated Regions | 1 | 2004 | 60 | 0.050 |
Why?
| | Brain | 5 | 2012 | 3009 | 0.050 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 676 | 0.050 |
Why?
| | Arginine | 1 | 2005 | 265 | 0.050 |
Why?
| | Fasting | 5 | 2004 | 280 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2001 | 163 | 0.050 |
Why?
| | Hemorrhage | 2 | 2006 | 832 | 0.050 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2008 | 442 | 0.050 |
Why?
| | Sex Factors | 3 | 2010 | 2136 | 0.050 |
Why?
| | Testosterone | 1 | 2007 | 417 | 0.050 |
Why?
| | Factor IX | 1 | 2003 | 49 | 0.050 |
Why?
| | Epithelial Cells | 2 | 2008 | 1141 | 0.050 |
Why?
| | Postoperative Complications | 1 | 1996 | 3022 | 0.050 |
Why?
| | Neoplasms | 2 | 2018 | 2946 | 0.050 |
Why?
| | Mental Disorders | 3 | 1998 | 1188 | 0.050 |
Why?
| | Protein Binding | 2 | 2012 | 2249 | 0.050 |
Why?
| | Nutritional Support | 1 | 2003 | 40 | 0.050 |
Why?
| | Kinetics | 6 | 2007 | 1569 | 0.050 |
Why?
| | Infant Food | 1 | 2003 | 69 | 0.050 |
Why?
| | Smoke | 1 | 2004 | 148 | 0.050 |
Why?
| | Mutagenesis, Insertional | 2 | 2012 | 69 | 0.050 |
Why?
| | Connective Tissue | 1 | 2002 | 38 | 0.050 |
Why?
| | Lyases | 1 | 2002 | 15 | 0.050 |
Why?
| | Brachial Artery | 2 | 2019 | 209 | 0.050 |
Why?
| | HeLa Cells | 1 | 2004 | 633 | 0.040 |
Why?
| | Glutamates | 1 | 2002 | 66 | 0.040 |
Why?
| | Mice, Mutant Strains | 2 | 2012 | 303 | 0.040 |
Why?
| | Cell Line, Tumor | 3 | 2005 | 3565 | 0.040 |
Why?
| | Guanine | 1 | 2002 | 85 | 0.040 |
Why?
| | Purpura, Thrombotic Thrombocytopenic | 1 | 2001 | 14 | 0.040 |
Why?
| | Pyridoxal Phosphate | 2 | 2011 | 20 | 0.040 |
Why?
| | Metalloendopeptidases | 1 | 2001 | 63 | 0.040 |
Why?
| | Vascular Diseases | 3 | 2004 | 252 | 0.040 |
Why?
| | Phenotype | 4 | 2014 | 3216 | 0.040 |
Why?
| | Methotrexate | 2 | 2015 | 235 | 0.040 |
Why?
| | Down-Regulation | 1 | 2004 | 618 | 0.040 |
Why?
| | Birth Weight | 1 | 2004 | 522 | 0.040 |
Why?
| | Molecular Weight | 5 | 1988 | 313 | 0.040 |
Why?
| | Surveys and Questionnaires | 4 | 2015 | 6164 | 0.040 |
Why?
| | Malonyl Coenzyme A | 3 | 1990 | 5 | 0.040 |
Why?
| | Models, Biological | 4 | 2012 | 1772 | 0.040 |
Why?
| | Respiration | 1 | 2021 | 208 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2000 | 7 | 0.040 |
Why?
| | New York | 2 | 2015 | 128 | 0.040 |
Why?
| | Papio | 1 | 2000 | 70 | 0.040 |
Why?
| | Citrates | 3 | 1998 | 41 | 0.040 |
Why?
| | Antigens, CD | 2 | 2001 | 562 | 0.040 |
Why?
| | Anemia, Macrocytic | 1 | 2000 | 4 | 0.040 |
Why?
| | Case-Control Studies | 5 | 2010 | 3660 | 0.040 |
Why?
| | Neurocognitive Disorders | 2 | 1992 | 33 | 0.040 |
Why?
| | Pregnancy Outcome | 2 | 2020 | 506 | 0.040 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2000 | 88 | 0.040 |
Why?
| | Sampling Studies | 1 | 2000 | 98 | 0.040 |
Why?
| | Coronary Artery Disease | 1 | 2006 | 754 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1994 | 593 | 0.040 |
Why?
| | Genetic Testing | 1 | 2003 | 493 | 0.040 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2001 | 279 | 0.040 |
Why?
| | Odds Ratio | 3 | 2002 | 1084 | 0.040 |
Why?
| | Oncogenes | 1 | 2020 | 118 | 0.040 |
Why?
| | Parenteral Nutrition | 1 | 2000 | 103 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1371 | 0.040 |
Why?
| | Embryo, Mammalian | 1 | 2020 | 234 | 0.040 |
Why?
| | Blotting, Northern | 3 | 2007 | 203 | 0.040 |
Why?
| | Cecum | 1 | 2019 | 37 | 0.040 |
Why?
| | Species Specificity | 2 | 2007 | 547 | 0.040 |
Why?
| | Nervous System Diseases | 2 | 1996 | 288 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 126 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2003 | 449 | 0.040 |
Why?
| | Kidney Function Tests | 1 | 1999 | 156 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 118 | 0.040 |
Why?
| | Reticulocyte Count | 2 | 2000 | 7 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 332 | 0.040 |
Why?
| | Pancytopenia | 1 | 1999 | 7 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2019 | 60 | 0.040 |
Why?
| | RNA | 2 | 2004 | 916 | 0.040 |
Why?
| | Stroke | 2 | 2005 | 1287 | 0.030 |
Why?
| | Metabolomics | 2 | 2017 | 736 | 0.030 |
Why?
| | Albuminuria | 1 | 1999 | 189 | 0.030 |
Why?
| | Nutrition Policy | 2 | 2010 | 57 | 0.030 |
Why?
| | Income | 1 | 1999 | 208 | 0.030 |
Why?
| | Papillomavirus E7 Proteins | 1 | 2018 | 11 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2000 | 261 | 0.030 |
Why?
| | Cross-Over Studies | 2 | 2014 | 617 | 0.030 |
Why?
| | Oligodendroglia | 1 | 2000 | 198 | 0.030 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 43 | 0.030 |
Why?
| | Estrogens | 1 | 2020 | 368 | 0.030 |
Why?
| | Pedigree | 2 | 2001 | 522 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 295 | 0.030 |
Why?
| | Tissue Distribution | 2 | 2011 | 335 | 0.030 |
Why?
| | Exons | 2 | 2011 | 365 | 0.030 |
Why?
| | Aspartate Aminotransferases | 2 | 2011 | 86 | 0.030 |
Why?
| | Central Nervous System Diseases | 1 | 1998 | 75 | 0.030 |
Why?
| | Lysosomes | 1 | 2017 | 133 | 0.030 |
Why?
| | Acetylcysteine | 2 | 2010 | 139 | 0.030 |
Why?
| | Cytosol | 1 | 2017 | 213 | 0.030 |
Why?
| | History, 20th Century | 2 | 2015 | 333 | 0.030 |
Why?
| | Alanine Transaminase | 2 | 2011 | 151 | 0.030 |
Why?
| | Angina Pectoris | 1 | 1997 | 76 | 0.030 |
Why?
| | 3T3-L1 Cells | 1 | 2016 | 36 | 0.030 |
Why?
| | Alcohol Drinking | 2 | 2001 | 858 | 0.030 |
Why?
| | Chronic Disease | 2 | 2011 | 1844 | 0.030 |
Why?
| | Enzyme Activation | 3 | 2005 | 762 | 0.030 |
Why?
| | Biological Transport | 1 | 2017 | 425 | 0.030 |
Why?
| | L-Lactate Dehydrogenase | 2 | 2000 | 112 | 0.030 |
Why?
| | Fatal Outcome | 2 | 2010 | 306 | 0.030 |
Why?
| | Anti-HIV Agents | 2 | 2001 | 919 | 0.030 |
Why?
| | Denmark | 1 | 2015 | 51 | 0.030 |
Why?
| | United States | 3 | 2020 | 16313 | 0.030 |
Why?
| | Cells, Cultured | 3 | 2012 | 4169 | 0.030 |
Why?
| | Glomerular Filtration Rate | 2 | 2011 | 765 | 0.030 |
Why?
| | Sulfaquinoxaline | 1 | 2015 | 1 | 0.030 |
Why?
| | Food, Formulated | 1 | 2015 | 16 | 0.030 |
Why?
| | Carbon Cycle | 1 | 2015 | 13 | 0.030 |
Why?
| | Body Weight | 2 | 2011 | 976 | 0.030 |
Why?
| | Hematologic Diseases | 1 | 1996 | 66 | 0.030 |
Why?
| | Quantitative Trait Loci | 1 | 2018 | 389 | 0.030 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1996 | 124 | 0.030 |
Why?
| | HIV Infections | 2 | 2001 | 3235 | 0.030 |
Why?
| | Enzyme Induction | 1 | 2015 | 88 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 5 | 2006 | 3980 | 0.030 |
Why?
| | Comorbidity | 1 | 2000 | 1672 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 1995 | 91 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2529 | 0.030 |
Why?
| | Hyaline Membrane Disease | 1 | 1994 | 20 | 0.030 |
Why?
| | Omasum | 1 | 2014 | 2 | 0.030 |
Why?
| | Coronary Artery Bypass | 1 | 1997 | 269 | 0.030 |
Why?
| | Parenteral Nutrition, Total | 1 | 1994 | 30 | 0.030 |
Why?
| | Histones | 1 | 2020 | 672 | 0.030 |
Why?
| | Mammary Glands, Human | 1 | 2015 | 71 | 0.030 |
Why?
| | Cricetinae | 2 | 2007 | 305 | 0.030 |
Why?
| | Fermentation | 1 | 2014 | 31 | 0.030 |
Why?
| | Cysteine Dioxygenase | 1 | 2014 | 3 | 0.030 |
Why?
| | Branchial Region | 1 | 2014 | 40 | 0.030 |
Why?
| | Family Health | 2 | 2006 | 195 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2018 | 429 | 0.030 |
Why?
| | Carboxy-Lyases | 1 | 2014 | 10 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2015 | 219 | 0.030 |
Why?
| | Intrinsic Factor | 2 | 2010 | 2 | 0.030 |
Why?
| | Renal Insufficiency | 2 | 1993 | 172 | 0.030 |
Why?
| | Larva | 1 | 2015 | 242 | 0.030 |
Why?
| | Isoelectric Focusing | 1 | 1994 | 30 | 0.030 |
Why?
| | Electrophoresis | 1 | 1994 | 31 | 0.030 |
Why?
| | Metabolome | 1 | 2018 | 391 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2014 | 91 | 0.030 |
Why?
| | History, 21st Century | 1 | 2015 | 227 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 480 | 0.030 |
Why?
| | Craniofacial Abnormalities | 1 | 2014 | 78 | 0.030 |
Why?
| | Radioisotope Dilution Technique | 3 | 1988 | 14 | 0.030 |
Why?
| | Animal Feed | 2 | 2009 | 50 | 0.020 |
Why?
| | Body Patterning | 1 | 2014 | 138 | 0.020 |
Why?
| | Chromatography, Affinity | 3 | 1988 | 82 | 0.020 |
Why?
| | Mammals | 1 | 2015 | 286 | 0.020 |
Why?
| | Myocardial Infarction | 2 | 2004 | 1213 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 334 | 0.020 |
Why?
| | Coronary Disease | 1 | 1996 | 382 | 0.020 |
Why?
| | Neural Crest | 1 | 2014 | 130 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 337 | 0.020 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 1994 | 139 | 0.020 |
Why?
| | Follow-Up Studies | 3 | 2015 | 5476 | 0.020 |
Why?
| | Litter Size | 1 | 2013 | 18 | 0.020 |
Why?
| | RNA, Viral | 2 | 2012 | 695 | 0.020 |
Why?
| | Hydrolysis | 1 | 2013 | 197 | 0.020 |
Why?
| | Dentate Gyrus | 1 | 2013 | 41 | 0.020 |
Why?
| | Blood Glucose | 2 | 2016 | 2359 | 0.020 |
Why?
| | Avitaminosis | 2 | 2007 | 6 | 0.020 |
Why?
| | Receptors, CCR2 | 1 | 2013 | 39 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2014 | 407 | 0.020 |
Why?
| | Rats, Inbred F344 | 2 | 1990 | 269 | 0.020 |
Why?
| | Anti-Bacterial Agents | 2 | 2015 | 1940 | 0.020 |
Why?
| | Tetrachloroethylene | 1 | 2012 | 3 | 0.020 |
Why?
| | Trichloroethylene | 1 | 2012 | 8 | 0.020 |
Why?
| | Tunicamycin | 1 | 2012 | 11 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2013 | 318 | 0.020 |
Why?
| | Ethylenes | 1 | 2012 | 16 | 0.020 |
Why?
| | Eating | 1 | 2015 | 387 | 0.020 |
Why?
| | Stroke Volume | 1 | 1996 | 658 | 0.020 |
Why?
| | Cell Differentiation | 2 | 2014 | 2054 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2012 | 105 | 0.020 |
Why?
| | Lipotropic Agents | 1 | 2012 | 5 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 1996 | 546 | 0.020 |
Why?
| | Protein Denaturation | 1 | 2012 | 76 | 0.020 |
Why?
| | Neurologic Examination | 1 | 1992 | 132 | 0.020 |
Why?
| | Hep G2 Cells | 1 | 2012 | 73 | 0.020 |
Why?
| | Biodegradation, Environmental | 1 | 2012 | 75 | 0.020 |
Why?
| | HIV Seropositivity | 1 | 1993 | 119 | 0.020 |
Why?
| | Sarcoma, Kaposi | 1 | 1993 | 83 | 0.020 |
Why?
| | Embryo Loss | 1 | 2012 | 4 | 0.020 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2012 | 24 | 0.020 |
Why?
| | Genes, Lethal | 1 | 2012 | 31 | 0.020 |
Why?
| | Chondrocytes | 1 | 2014 | 232 | 0.020 |
Why?
| | Hypoxanthine | 1 | 2012 | 11 | 0.020 |
Why?
| | Postpartum Period | 1 | 2015 | 379 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2016 | 646 | 0.020 |
Why?
| | Patient Selection | 1 | 1996 | 746 | 0.020 |
Why?
| | Random Allocation | 1 | 2012 | 366 | 0.020 |
Why?
| | Factor Analysis, Statistical | 1 | 2013 | 296 | 0.020 |
Why?
| | Catalase | 1 | 2012 | 134 | 0.020 |
Why?
| | Lipoproteins | 1 | 2013 | 166 | 0.020 |
Why?
| | S Phase | 1 | 2011 | 78 | 0.020 |
Why?
| | Radioligand Assay | 1 | 2011 | 36 | 0.020 |
Why?
| | Ferritins | 1 | 2011 | 70 | 0.020 |
Why?
| | Necrosis | 1 | 2012 | 245 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2011 | 117 | 0.020 |
Why?
| | Microbiological Techniques | 1 | 2011 | 30 | 0.020 |
Why?
| | Diet, High-Fat | 1 | 2013 | 267 | 0.020 |
Why?
| | Chemokine CCL4 | 1 | 2011 | 31 | 0.020 |
Why?
| | Capsid Proteins | 1 | 2012 | 94 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 2 | 2001 | 41 | 0.020 |
Why?
| | Breast Feeding | 1 | 2015 | 447 | 0.020 |
Why?
| | Epithelium | 1 | 2012 | 311 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 173 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2011 | 192 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2012 | 278 | 0.020 |
Why?
| | Chromatography, Ion Exchange | 2 | 1988 | 57 | 0.020 |
Why?
| | Ethanol | 1 | 1996 | 634 | 0.020 |
Why?
| | Chromatography, Gel | 2 | 1988 | 131 | 0.020 |
Why?
| | Nitrous Oxide | 1 | 1991 | 34 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1991 | 323 | 0.020 |
Why?
| | Interleukin-1alpha | 1 | 2011 | 57 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 85 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 410 | 0.020 |
Why?
| | Transgenes | 1 | 2011 | 190 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 773 | 0.020 |
Why?
| | Protein Conformation | 1 | 1994 | 943 | 0.020 |
Why?
| | Gastrins | 1 | 1990 | 8 | 0.020 |
Why?
| | Mitochondrial Diseases | 1 | 2011 | 94 | 0.020 |
Why?
| | Reference Standards | 1 | 2011 | 177 | 0.020 |
Why?
| | Serum Albumin | 1 | 2011 | 147 | 0.020 |
Why?
| | Neuroblastoma | 1 | 2012 | 177 | 0.020 |
Why?
| | Peroxidase | 1 | 2011 | 168 | 0.020 |
Why?
| | Acid Anhydride Hydrolases | 1 | 2010 | 8 | 0.020 |
Why?
| | Placebos | 2 | 2005 | 193 | 0.020 |
Why?
| | Renal Dialysis | 1 | 1995 | 467 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2013 | 537 | 0.020 |
Why?
| | Macromolecular Substances | 2 | 1988 | 216 | 0.020 |
Why?
| | Hypertension | 1 | 1999 | 1280 | 0.020 |
Why?
| | Tumor Burden | 1 | 2012 | 327 | 0.020 |
Why?
| | Mitochondria, Liver | 1 | 1990 | 70 | 0.020 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2010 | 19 | 0.020 |
Why?
| | Interleukin-17 | 1 | 2011 | 123 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2004 | 2679 | 0.020 |
Why?
| | Staining and Labeling | 1 | 2010 | 153 | 0.020 |
Why?
| | Hydroxybutyrates | 1 | 1990 | 15 | 0.020 |
Why?
| | Bilirubin | 1 | 1990 | 102 | 0.020 |
Why?
| | Monocytes | 1 | 2013 | 539 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1994 | 2134 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 507 | 0.020 |
Why?
| | Stem Cells | 1 | 2014 | 630 | 0.020 |
Why?
| | Cell Movement | 1 | 2014 | 966 | 0.020 |
Why?
| | Zebrafish | 1 | 2014 | 536 | 0.020 |
Why?
| | Purines | 1 | 2011 | 188 | 0.020 |
Why?
| | Aorta | 1 | 2013 | 443 | 0.020 |
Why?
| | Dairying | 1 | 2009 | 12 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 1991 | 567 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2012 | 745 | 0.020 |
Why?
| | Helicobacter pylori | 1 | 2010 | 44 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 751 | 0.020 |
Why?
| | Fear | 1 | 2013 | 373 | 0.020 |
Why?
| | Mexican Americans | 1 | 2010 | 119 | 0.020 |
Why?
| | Bacteria | 1 | 2015 | 769 | 0.020 |
Why?
| | Hemostasis | 1 | 2010 | 100 | 0.020 |
Why?
| | Nigeria | 1 | 2009 | 24 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2012 | 375 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2011 | 311 | 0.020 |
Why?
| | Burkitt Lymphoma | 1 | 1989 | 61 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2011 | 430 | 0.020 |
Why?
| | Muscles | 1 | 1990 | 330 | 0.020 |
Why?
| | Acetylcarnitine | 1 | 1988 | 6 | 0.020 |
Why?
| | Peroxides | 1 | 2008 | 18 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2013 | 1140 | 0.020 |
Why?
| | Body Composition | 1 | 2013 | 694 | 0.020 |
Why?
| | Osteosarcoma | 1 | 1989 | 100 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2012 | 366 | 0.020 |
Why?
| | Microchemistry | 1 | 1988 | 19 | 0.020 |
Why?
| | Duodenum | 1 | 2009 | 80 | 0.020 |
Why?
| | Isoleucine | 1 | 1988 | 15 | 0.020 |
Why?
| | Silicon | 1 | 1988 | 19 | 0.020 |
Why?
| | Amino Acids, Branched-Chain | 1 | 1988 | 39 | 0.020 |
Why?
| | Catalytic Domain | 1 | 2009 | 234 | 0.020 |
Why?
| | Health Status Disparities | 1 | 2011 | 324 | 0.020 |
Why?
| | Multivariate Analysis | 2 | 2002 | 1550 | 0.020 |
Why?
| | Ethiopia | 1 | 2008 | 44 | 0.020 |
Why?
| | Predictive Value of Tests | 3 | 2000 | 2133 | 0.020 |
Why?
| | Tritium | 1 | 1988 | 67 | 0.020 |
Why?
| | Thiolester Hydrolases | 1 | 1988 | 13 | 0.020 |
Why?
| | Biopsy | 1 | 2011 | 1093 | 0.020 |
Why?
| | Ileum | 1 | 2009 | 112 | 0.020 |
Why?
| | Blood Coagulation Disorders | 1 | 2010 | 198 | 0.020 |
Why?
| | Zea mays | 1 | 2008 | 45 | 0.020 |
Why?
| | Haplotypes | 1 | 2010 | 509 | 0.020 |
Why?
| | Alzheimer Disease | 1 | 1994 | 639 | 0.020 |
Why?
| | Valine | 1 | 1988 | 83 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2011 | 575 | 0.020 |
Why?
| | Pyrimidines | 1 | 2011 | 532 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2008 | 248 | 0.020 |
Why?
| | Embryonic Development | 1 | 2008 | 125 | 0.020 |
Why?
| | Fibrosis | 1 | 2010 | 568 | 0.020 |
Why?
| | Ambulatory Care | 1 | 1992 | 625 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 392 | 0.020 |
Why?
| | Kidney Cortex | 1 | 2007 | 27 | 0.020 |
Why?
| | Guanidinoacetate N-Methyltransferase | 1 | 2007 | 4 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2007 | 159 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2013 | 693 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2011 | 784 | 0.020 |
Why?
| | Prenatal Care | 1 | 2009 | 310 | 0.020 |
Why?
| | Infusions, Intravenous | 2 | 2003 | 430 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2006 | 72 | 0.020 |
Why?
| | Ambulatory Care Facilities | 1 | 2009 | 269 | 0.020 |
Why?
| | Creatine | 1 | 2007 | 63 | 0.020 |
Why?
| | Injections, Intramuscular | 2 | 1998 | 147 | 0.020 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2006 | 31 | 0.010 |
Why?
| | von Willebrand Diseases | 1 | 2006 | 28 | 0.010 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1989 | 299 | 0.010 |
Why?
| | Rabbits | 1 | 2007 | 654 | 0.010 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2010 | 415 | 0.010 |
Why?
| | Public Health | 1 | 2011 | 577 | 0.010 |
Why?
| | Gene Frequency | 1 | 2007 | 498 | 0.010 |
Why?
| | Respiratory Mucosa | 1 | 2008 | 324 | 0.010 |
Why?
| | Dicarboxylic Acids | 1 | 1985 | 12 | 0.010 |
Why?
| | Models, Genetic | 1 | 2008 | 536 | 0.010 |
Why?
| | Muscular Diseases | 1 | 2006 | 109 | 0.010 |
Why?
| | Edible Grain | 1 | 2005 | 47 | 0.010 |
Why?
| | Croatia | 1 | 2005 | 4 | 0.010 |
Why?
| | Transaminases | 1 | 2005 | 22 | 0.010 |
Why?
| | Dipeptides | 1 | 2005 | 56 | 0.010 |
Why?
| | Creatine Kinase | 1 | 2005 | 72 | 0.010 |
Why?
| | HIV-1 | 2 | 2001 | 917 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2005 | 88 | 0.010 |
Why?
| | New York City | 1 | 2004 | 87 | 0.010 |
Why?
| | RNA Interference | 1 | 2006 | 477 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2013 | 2017 | 0.010 |
Why?
| | tert-Butylhydroperoxide | 1 | 2004 | 9 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2007 | 1266 | 0.010 |
Why?
| | Metals | 1 | 1985 | 138 | 0.010 |
Why?
| | Apolipoprotein E4 | 1 | 2004 | 47 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2005 | 891 | 0.010 |
Why?
| | Models, Molecular | 1 | 2009 | 1606 | 0.010 |
Why?
| | Neurons | 1 | 2013 | 1672 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2011 | 17560 | 0.010 |
Why?
| | Psychological Tests | 1 | 2004 | 131 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2005 | 422 | 0.010 |
Why?
| | Hemostasis, Surgical | 1 | 2003 | 25 | 0.010 |
Why?
| | Hepatocytes | 1 | 2004 | 224 | 0.010 |
Why?
| | Depression | 1 | 2013 | 1599 | 0.010 |
Why?
| | Myelin Sheath | 1 | 2005 | 168 | 0.010 |
Why?
| | Inactivation, Metabolic | 1 | 2002 | 9 | 0.010 |
Why?
| | Ascorbic Acid | 1 | 2004 | 184 | 0.010 |
Why?
| | Colorado | 1 | 1992 | 4591 | 0.010 |
Why?
| | Enzyme Stability | 1 | 2002 | 74 | 0.010 |
Why?
| | Pemetrexed | 1 | 2002 | 40 | 0.010 |
Why?
| | Cricetulus | 1 | 2002 | 118 | 0.010 |
Why?
| | Citrate (si)-Synthase | 2 | 1993 | 57 | 0.010 |
Why?
| | Autoantibodies | 1 | 2010 | 1513 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2005 | 627 | 0.010 |
Why?
| | Drug Contamination | 1 | 2002 | 56 | 0.010 |
Why?
| | Carcinoma | 1 | 2004 | 231 | 0.010 |
Why?
| | Physical Chromosome Mapping | 1 | 2001 | 21 | 0.010 |
Why?
| | Brain Death | 1 | 2002 | 60 | 0.010 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2001 | 36 | 0.010 |
Why?
| | Hepatomegaly | 1 | 2001 | 4 | 0.010 |
Why?
| | Vasodilation | 1 | 2005 | 522 | 0.010 |
Why?
| | Transcription Factors | 1 | 2010 | 1747 | 0.010 |
Why?
| | Sex Characteristics | 1 | 2007 | 799 | 0.010 |
Why?
| | Radiography | 1 | 2004 | 862 | 0.010 |
Why?
| | Computational Biology | 1 | 2006 | 677 | 0.010 |
Why?
| | Treatment Refusal | 1 | 2002 | 99 | 0.010 |
Why?
| | Hypertension, Renal | 1 | 2001 | 15 | 0.010 |
Why?
| | Coffee | 1 | 2001 | 16 | 0.010 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2003 | 159 | 0.010 |
Why?
| | Tea | 1 | 2001 | 17 | 0.010 |
Why?
| | Multigene Family | 1 | 2001 | 210 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2003 | 789 | 0.010 |
Why?
| | Kidney Transplantation | 1 | 2007 | 732 | 0.010 |
Why?
| | Chromatography, Gas | 1 | 2000 | 30 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2005 | 1730 | 0.010 |
Why?
| | Cell Survival | 1 | 2004 | 1111 | 0.010 |
Why?
| | Bone Marrow Diseases | 1 | 2000 | 20 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 2002 | 347 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2001 | 512 | 0.010 |
Why?
| | Culture Media, Conditioned | 1 | 2000 | 112 | 0.010 |
Why?
| | Platelet Count | 1 | 2000 | 95 | 0.010 |
Why?
| | Liver Transplantation | 1 | 2007 | 841 | 0.010 |
Why?
| | Ultrasonography | 1 | 2004 | 795 | 0.010 |
Why?
| | Kynurenine | 1 | 2000 | 114 | 0.010 |
Why?
| | Leukocyte Count | 1 | 2000 | 319 | 0.010 |
Why?
| | Probability | 1 | 2000 | 309 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2000 | 430 | 0.010 |
Why?
| | Hypersplenism | 1 | 1999 | 9 | 0.010 |
Why?
| | Rats, Wistar | 1 | 2000 | 450 | 0.010 |
Why?
| | Tryptophan | 1 | 2000 | 183 | 0.010 |
Why?
| | Zimbabwe | 1 | 1999 | 76 | 0.010 |
Why?
| | Anemia, Aplastic | 1 | 1999 | 42 | 0.010 |
Why?
| | Chromatography, DEAE-Cellulose | 2 | 1988 | 10 | 0.010 |
Why?
| | Carbon Radioisotopes | 2 | 1988 | 29 | 0.010 |
Why?
| | Incidence | 1 | 2005 | 2954 | 0.010 |
Why?
| | Viral Load | 1 | 2000 | 528 | 0.010 |
Why?
| | Life Style | 1 | 2001 | 504 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 836 | 0.010 |
Why?
| | Indicators and Reagents | 2 | 1988 | 106 | 0.010 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2000 | 267 | 0.010 |
Why?
| | Demyelinating Diseases | 1 | 1998 | 84 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2000 | 1046 | 0.010 |
Why?
| | Drug Overdose | 1 | 2002 | 381 | 0.010 |
Why?
| | Antihypertensive Agents | 1 | 2001 | 522 | 0.010 |
Why?
| | Theophylline | 1 | 1996 | 41 | 0.010 |
Why?
| | Genes | 1 | 1996 | 230 | 0.010 |
Why?
| | Leukemia | 1 | 1999 | 247 | 0.010 |
Why?
| | Deoxyuracil Nucleotides | 1 | 1996 | 4 | 0.010 |
Why?
| | Thymine Nucleotides | 1 | 1996 | 19 | 0.010 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 1996 | 48 | 0.010 |
Why?
| | Diet Surveys | 1 | 1996 | 91 | 0.010 |
Why?
| | Swine, Miniature | 1 | 1996 | 89 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 1049 | 0.010 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1996 | 130 | 0.010 |
Why?
| | Bronchodilator Agents | 1 | 1996 | 187 | 0.010 |
Why?
| | Age of Onset | 1 | 1996 | 568 | 0.010 |
Why?
| | Radioimmunoassay | 1 | 1994 | 165 | 0.010 |
Why?
| | Autopsy | 1 | 1994 | 96 | 0.010 |
Why?
| | Cell Division | 1 | 1996 | 758 | 0.010 |
Why?
| | Wounds and Injuries | 1 | 2003 | 977 | 0.010 |
Why?
| | Chromatography | 1 | 1993 | 27 | 0.010 |
Why?
| | Belgium | 1 | 1993 | 11 | 0.010 |
Why?
| | Treatment Failure | 1 | 1995 | 360 | 0.010 |
Why?
| | Massachusetts | 1 | 1994 | 181 | 0.010 |
Why?
| | Netherlands | 1 | 1993 | 85 | 0.010 |
Why?
| | Stereoisomerism | 1 | 1993 | 103 | 0.010 |
Why?
| | Swine | 1 | 1996 | 828 | 0.010 |
Why?
| | Germany | 1 | 1993 | 140 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2002 | 2458 | 0.010 |
Why?
| | Blood Chemical Analysis | 1 | 1993 | 109 | 0.010 |
Why?
| | Culture Media | 1 | 1993 | 161 | 0.010 |
Why?
| | Borohydrides | 1 | 1991 | 1 | 0.010 |
Why?
| | Mercaptoethanol | 1 | 1991 | 8 | 0.010 |
Why?
| | Plasma | 1 | 1993 | 224 | 0.010 |
Why?
| | Spectrum Analysis | 1 | 1991 | 85 | 0.010 |
Why?
| | Glutamate Dehydrogenase | 1 | 1990 | 4 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2002 | 2231 | 0.000 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 1990 | 49 | 0.000 |
Why?
| | Succinate Dehydrogenase | 1 | 1990 | 65 | 0.000 |
Why?
| | Molecular Structure | 1 | 1991 | 488 | 0.000 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 1994 | 394 | 0.000 |
Why?
| | Glucose | 1 | 1994 | 1051 | 0.000 |
Why?
| | Light | 1 | 1991 | 403 | 0.000 |
Why?
| | Erythrocyte Indices | 1 | 1988 | 33 | 0.000 |
Why?
| | Hypesthesia | 1 | 1988 | 21 | 0.000 |
Why?
| | Ataxia | 1 | 1988 | 69 | 0.000 |
Why?
| | Oxygen Consumption | 1 | 1990 | 721 | 0.000 |
Why?
| | Intestines | 1 | 1990 | 356 | 0.000 |
Why?
| | Celiac Disease | 1 | 1990 | 314 | 0.000 |
Why?
| | Algorithms | 1 | 1994 | 1868 | 0.000 |
Why?
| | Models, Theoretical | 1 | 1989 | 563 | 0.000 |
Why?
| | Chemistry | 1 | 1985 | 41 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1985 | 77 | 0.000 |
Why?
| | Proteins | 1 | 1990 | 1024 | 0.000 |
Why?
| | Asthma | 1 | 1996 | 1805 | 0.000 |
Why?
|
|
Stabler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|